SCHEMBL6797692

SCHEMBL6797692

COc1cc(-c2cc(=O)c3ccc(OC)c(OC)c3o2)cc(O)c1OC

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.66
CYP1A2 P05177 2/20 0.66
CYP2C19 P33261 2/20 0.66
NCOA1 Q15788 1/20 0.66
NCOA3 Q9Y6Q9 1/20 0.66
TERT O14746 7/20 0.63
CYP1A1 P04798 2/20 0.60
CYP1B1 Q16678 2/20 0.60
PABPC1 P11940 1/20 0.59
ALDH1A1 P00352 2/20 0.57
MAPT P10636 1/20 0.57
CYP2C9 P11712 1/20 0.57
HPGD P15428 1/20 0.57
CSNK2A2 P19784 2/20 0.56
CSNK2B P67870 2/20 0.56
CSNK2A1 P68400 2/20 0.56
ACHE P22303 1/20 0.55
PLK1 P53350 1/20 0.55
BACE1 P56817 1/20 0.55
TUBB4A P04350 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6803222 0.91 TERT (0.74) CYP3A4CYP1A2CYP2C19NCOA1NCOA3
SCHEMBL6613755 0.89 TERT (0.77) CYP3A4CYP1A2CYP2C19NCOA1NCOA3
SCHEMBL6803148 0.88 TERT (0.80) CYP3A4CYP1A2CYP2C19NCOA1NCOA3
SCHEMBL5442940 0.87 TUBB4A (0.67) CYP3A4CYP1A2TERTCYP1A1CYP1B1
SCHEMBL6802299 0.85 CYP1A2 (0.63) CYP3A4CYP1A2CYP2C19NCOA1NCOA3
SCHEMBL29612043 0.84 TERT (0.77) CYP3A4CYP1A2CYP2C19NCOA1NCOA3
SCHEMBL988001 0.84 TERT (0.77) CYP3A4CYP1A2CYP2C19NCOA1NCOA3
SCHEMBL6802044 0.84 TERT (0.77) CYP3A4CYP1A2CYP2C19TERTCYP1A1
SCHEMBL22230886 0.83 CYP1A1 (0.58) CYP3A4CYP1A2TERTCYP1A1CYP1B1
SCHEMBL6614365 0.82 TERT (0.80) CYP3A4CYP1A2CYP2C19NCOA1NCOA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2004-04-01 US disclosed
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2002-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP CYP3A4 3385/4885CYP1A2 3159/4885CYP2C19 3703/4885
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP CYP3A4 3411/4885CYP1A2 3209/4885CYP2C19 3745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.